TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Applera Corp-Celera Genomics Group Q1 2010 Earnings Call Transcript Applera Corp-Celera Genomics Group (CRA)Q1 2010 Earnings Conference Call April 28, 2010 4:30 PM ETComplete Story » seekingalpha.com |
Targacept: Ready to Take Off Jason Chew submits: Targacept (TRGT) is a company focused on CNS diseases and disorders, targeting Neuronal Nicotinic Receptors (NNRs). As a company spun off from R.J Reynolds and still located in Winston-Salem, it knows a thing or two about this subject.NNRs are ion channels that open in response to the binding of the neurotransmitter acetylcholine allowing the flow of sodium and potassium ions across the cell membrane. NNRs have effects on learning, memory, reward, and other functions. Neuronal Nicotinic Receptors are called such because they are bound and activated by nicotine as well as acetylcholine. Two of most abundant NNR subtypes are α4β2 and α7. These two subtypes are thought to be involved in a host of disorders ranging from Alzheimer’s Disease, nicotine addiction, schizophrenia, and Parkinson’s Disease, among others. Complete Story » seekingalpha.com |
New Test for Brain Injury on Horizon Scientists are close to identifying "biomarkers" that could make it possible to pinpoint brain injuries with a simple blood test. online.wsj.com |
Covance to Present at Morgan Stanley Global Healthcare Conference [PR Newswire] - Covance Inc. today announced that it will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 14, 2010 at 2:10 p.m. ET. Â Investors may access a live webcast of the presentation at www.covance.com. Â In order to register and download any necessary software, please log on 10 minutes early. us.rd.yahoo.com |
Principal Financial Quits Writing Health-Care Policies Financial services provider Principal Financial Group is exiting the health-insurance business in an early sign of expected industry consolidation as the impact of the health overhaul becomes clearer. online.wsj.com |